Get Sample Pages - U.S. Anemia Treatment Market Analysis, Growth & Size

U.S. Anemia Treatment Market Research Report Forecast: (2025-2030)

U.S. Anemia Treatment Market - By Disease Type (Iron Deficiency Anemia, Sickle Cell Anemia, Aplastic Anemia, Vitamin Deficiency Anemia), By Drug (Bone Marrow Stimulants, Gene Thera......py, Corticosteroids, Iron Chelating Agents, Supplements [Iron, Vitamin B12, Folic Acid]) and Others Read more

Healthcare
Feb 2025
Pages 114
Report Format: PDF, Excel, PPT

Market Definition

Anemia treatment must be conscious of addressing the underlying causes, inclusive of iron deficiency, vitamin deficiency, folate deficiency, persistent illnesses, or blood loss. Treatment alternatives might also involve iron supplements, vitamin supplements, erythropoiesis-stimulating sellers, blood transfusions, and, in certain cases, gene remedies.

Market Insights & Analysis: U.S. Anemia Treatment Market (2025-30):

The U.S. Anemia Treatment Market size was valued at around USD 1.07 billion in 2024 and is projected to reach USD 1.98 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.14% during the forecast period, i.e., 2025-30. The U.S. Anemia Treatment Market has substantial growth as a result of multiple factors such as accidents and increased surgical treatments, resulting in a growing incidence rate of blood disorders. This can be seen in iron deficiency, which is the most common reason behind anemia. For instance, the number of anemia diagnoses has been increasing due to the rise in the aging population, especially among elderly people, who might have a higher risk of chronic diseases, such as kidney disease and cancer. Both of these conditions have higher chances of anemia.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD 1.07 Billion
Market Value in 2030	USD 1.98 Billion
CAGR (2025-30)	10.14%
Leading Region	South Region
Top Key Players	Pfizer, Novartis, Roche, Amgen, Bayer, Teva Pharmaceuticals, AMAG Pharmaceuticals, Akebia Therapeutics, Janssen Pharmaceuticals, Inc. Vigor Pharma Management Ltd. Abbot, Sanofi, and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

However, the rising number of accidents and surgeries raises the need for anemia treatment. For instance, as per the National Trauma Institute, around 2 million people are treated with traumatic injuries annually in the U.S. Such injuries lead to a huge amount of blood loss and require immediate medical attention to control anemia. Due to the increased chance of getting anemia cases as a result of surgeries involving loss or post-surgical complications, replacement surgery at the joint and heart-related surgeries lead to blood-related complications. Hence, hospital and emergency care are growing to present better treatment solutions for anemia. As the demand for better anemia management continues to grow, pharmaceutical companies have started with innovative therapies that provide better and more convenient treatment options for patients, and expanding the market.

For instance, the U. S. Food and Drug Administration is consistently approving new drugs and treatments for anemia. Recently, it approved Jesduvroq tablets (daprodustat) for the oral treatment of anemia related to chronic kidney disease in adult patients who have been undergoing dialysis for a minimum of four months. This emphasis on R&D is advancing the creation of more personalized anemia treatments, including oral iron supplements with improved absorption, intravenous iron therapies, and innovative biologics such as erythropoiesis-stimulating agents (ESAs). Consequently, the U. S. anemia treatment industry is poised for substantial growth in the coming years, as ongoing R&D investments will facilitate enhanced solutions for patients and healthcare providers.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
U.S. Anemia Treatment Market Regulations and Policy
U.S. Anemia Treatment Market Trends & Developments
U.S. Anemia Treatment Market Supply Chain Analysis
U.S. Anemia Treatment Market Dynamics
1. Drivers
2. Challenges
U.S. Anemia Treatment Market Hotspots & Opportunities
U.S. Anemia Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Disease Type
    1. Iron Deficiency Anemia-Market Size & Forecast 2020-2030, (USD Million)
    2. Sickle Cell Anemia-Market Size & Forecast 2020-2030, (USD Million)
    3. Aplastic Anemia-Market Size & Forecast 2020-2030, (USD Million)
    4. Vitamin Deficiency Anemia-Market Size & Forecast 2020-2030, (USD Million)
  2. By Drug
    1. Bone Marrow Stimulants- Market Size & Forecast 2020-2030, (USD Million)
    2. Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
    3. Corticosteroids- Market Size & Forecast 2020-2030, (USD Million)
    4. Iron Chelating Agents-Market Size & Forecast 2020-2030, (USD Million)
    5. Supplements-Market Size & Forecast 2020-2030, (USD Million)
      1. Iron-Market Size & Forecast 2020-2030, (USD Million)
      2. Vitamin B12-Market Size & Forecast 2020-2030, (USD Million)
      3. Folic Acid-Market Size & Forecast 2020-2030, (USD Million)
  3. By Region
    1. North
    2. East
    3. Mid-West
    4. South
  4. By Company
    1. Market Share
    2. Competition Characteristics
U.S. Iron Deficiency Anemia Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug - Market Size & Forecast 2020-2030, (USD Million)
  2. By Region - Market Size & Forecast 2020-2030, (USD Million)
U.S. Sickle Cell Anemia Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
2. Market Share & Analysis
  1. By Drug - Market Size & Forecast 2020-2030, (USD Million)
  2. By Region - Market Size & Forecast 2020-2030, (USD Million)
U.S. Aplastic Deficiency Anemia Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug - Market Size & Forecast 2020-2030, (USD Million)
  2. By Region - Market Size & Forecast 2020-2030, (USD Million)
U.S. Vitamin Deficiency Anemia Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug - Market Size & Forecast 2020-2030, (USD Million)
  2. By Region - Market Size & Forecast 2020-2030, (USD Million)
Competitive Outlook
1. Company Profiles
  1. Pfizer
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Novartis
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Roche
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Amgen
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Bayer
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Teva Pharmaceuticals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. AMAG Pharmaceuticals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Akebia Therapeutics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Janssen Pharmaceuticals, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Vifor Pharma Management Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Abbott
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Sanofi.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *